Search - tctmd.com

Displaying 141 - 160 of 191

Sort: Relevancy | Date

Presentation TCT 2014

Yes, It Is a Good Option for Most Anticoagulation Eligible Patients

Presenter: Saibal Kar

September 15, 2014

Presentation TCT 2014

The REG1 Anticoagulation System: Factor IX Inhibitor Using RNA Aptamer Technology

Presenter: E. Magnus Ohman, Freek W.A. Verheugt, C. Michael Gibson, A. Michael Lincoff

September 15, 2014

Presentation TCT 2014

No, It Should Be Limited to Patients with Absolute Anticoagulation Contraindications

Presenter: Jai-Wun Park

September 15, 2014

Presentation TCT 2014

PCI and Anticoagulation: Triple Therapy

Presenter: Jurrien M. Ten Berg

September 13, 2014

Presentation

Post-Procedural Anticoagulation for Specific Indications After Revascularization for STEMI

Presenter: M. V. Madhavan

August 27, 2014

Presentation

Catheter-Directed Thrombolysis Plus Anticoagulation vs Anticoagulation Alone to Treat Lower-Extremity Proximal DVT

Presenter: Riyaz Bashir

July 22, 2014

Presentation

Use of the REG1 Anticoagulation System in Patients with ACS Undergoing PCI

Presenter: Thomas J. Povsic

June 27, 2014

Presentation TVT 2014

Dynamics in Gradients after Aortic Valve-in-Valve Implantation: An Argument for Anticoagulation Treatment

Presenter: Danny Dvir

June 05, 2014

Presentation EuroPCR 2014

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

Presenter: Jos? Ram?n L?pez-M?nguez

May 21, 2014

Presentation

A Phase 2 Placebo-Controlled Trial Demonstrating Reversal of Rivaroxaban-induced Anticoagulation

Presenter: Mark Crowther

December 22, 2013

Presentation TCT 2013

Indications for Chronic Oral Anticoagulation After Primary PCI in STEMI and Recommended Regimens

Presenter: Harvey White

October 31, 2013

Presentation TCT 2013

Case #1: Fibrinolysis or Aggressive Pre-hospital Anticoagulation to Prevent Complications During Long Distance Transfer?

Presenter: Peter Clemmensen

October 31, 2013

Presentation TCT 2013

Anticoagulation For Prosthetic Valves: Warfarin for Mechanical Valves

Presenter: Bernard Gersh

October 31, 2013

Presentation TCT 2013

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Presenter: Brian Whisenant

October 30, 2013

Presentation TCT 2013

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Presenter: Miroslava Stolcova

October 29, 2013

Presentation TCT 2013

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke

Presenter: Saibal Kar

October 29, 2013

Presentation TCT 2013

Triple Therapy (DAPT Plus Chronic Oral Anticoagulation): Risks and Therapeutic Alternatives

Presenter: Eugenia Nikolsky

October 28, 2013

Presentation TCT 2013

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Presenter: George Dangas

October 28, 2013

Presentation TCT 2013

Stroke, Bleeding and Risk Scores in Atrial Fibrillation (with and without Anticoagulation)

Presenter: Stefan Bertog

October 27, 2013

Presentation TCT 2013

Current Use Patterns of Chronic Oral Anticoagulation: Penetration, Agent Selection, Complications, and Defining the Anticoagulant Ineligible Patient

Presenter: Michael Ezekowitz

October 27, 2013

Advertisement

Yes, It Is a Good Option for Most Anticoagulation Eligible Patients

The REG1 Anticoagulation System: Factor IX Inhibitor Using RNA Aptamer Technology

No, It Should Be Limited to Patients with Absolute Anticoagulation Contraindications

PCI and Anticoagulation: Triple Therapy

Post-Procedural Anticoagulation for Specific Indications After Revascularization for STEMI

Catheter-Directed Thrombolysis Plus Anticoagulation vs Anticoagulation Alone to Treat Lower-Extremity Proximal DVT

Use of the REG1 Anticoagulation System in Patients with ACS Undergoing PCI

Dynamics in Gradients after Aortic Valve-in-Valve Implantation: An Argument for Anticoagulation Treatment

Two-year clinical outcome after left atrial appendage closure with the Amplatzer Cardiac Plug device in patients with non-valvular atrial fibrillation and contraindications for anticoagulation therapy

A Phase 2 Placebo-Controlled Trial Demonstrating Reversal of Rivaroxaban-induced Anticoagulation

Indications for Chronic Oral Anticoagulation After Primary PCI in STEMI and Recommended Regimens

Case #1: Fibrinolysis or Aggressive Pre-hospital Anticoagulation to Prevent Complications During Long Distance Transfer?

Anticoagulation For Prosthetic Valves: Warfarin for Mechanical Valves

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Left Atrial Appendage Occlusion: A Valid Option to Anticoagulation for Long-term Prevention of Stroke

Triple Therapy (DAPT Plus Chronic Oral Anticoagulation): Risks and Therapeutic Alternatives

Anticoagulation and Antiplatelet Regimens After TAVR: Bivalirudin (BRAVO 2/3 Trial) and Other Alternatives

Stroke, Bleeding and Risk Scores in Atrial Fibrillation (with and without Anticoagulation)

Current Use Patterns of Chronic Oral Anticoagulation: Penetration, Agent Selection, Complications, and Defining the Anticoagulant Ineligible Patient

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content